Promising Drug Target for Cystic Fibrosis (IMAGE) European Molecular Biology Laboratory Caption Promising drug target: inhibiting DGKι reduces ENaC activity, reversing the effects of cystic fibrosis. In this assay, the green glow dims more in cells with active ENaC (bottom), so the scientists screened for cases where the cells' glow barely changed (top). Credit EMBL/Pepperkok Usage Restrictions EMBL press and picture releases including photographs, graphics and videos are copyrighted by EMBL. They may be freely reprinted and distributed for non-commercial use via print, broadcast and electronic media, provided that proper attribution to authors, photographers and designers is made. High-resolution copies of the images can be downloaded from the EMBL web site: <a target="_blank"href="http://www.embl.org">www.embl.org</a>. License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.